Your search history is turned on.
Date: April 8, 2024 Jurisdictions: Alberta, British Columbia, Ontario
_ Form 52-109FV1 Certification of annual filings - venture issuer basic certificate I, Rebecca Hudson, Chief Financial Officer of Nova Mentis Life Science Corp., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and info...
Date: April 8, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, PLADSON, Kelly, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonabl...
_ Form 52-109FV1 Certification of annual filings - venture issuer basic certificate I, William Rascan, Chief Executive Officer of Nova Mentis Life Science Corp., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and info...
Managements Discussion and Analysis Years Ended December 31, 2023 and 2022 NOVA MENTIS LIFE SCIENCE CORP. MANAGEMENT DISCUSSION & ANALYSIS FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022 2 | P a g e 1.0 INTRODUCTION The following discussion and analysis are a review of the operations, c...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
NOVA Financial Statements - December 31, 2023 Draft V6 Final Consolidated Financial Statements Years Ended December 31, 2023 and 2022 Years Ended December 31, 2023 and 2022 INDEX Page Audit Report 3 Consolidated Financial Statements Consolidated Statements of Financial Position 6 Consolidated Statements of Loss and Comprehensive Loss 7 Consolidated State...
Date: February 26, 2024 Jurisdictions: Alberta, British Columbia, Ontario
1 Nova Mentis Announces Change of Directors Vancouver, British Columbia February 26, 2024 Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (NOVA or the Company) announces the appointment of Steve Loutskou to the Companys Board of Directors, effective February 23, 2024. Mr. Loutskou, a seasoned serial entrepr...
Date: January 3, 2024 Jurisdictions: Alberta, British Columbia, Ontario
1 Nova Mentis Announces Change of Directors and Officers Vancouver, British Columbia January 03, 2023 Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (NOVA or the Company) announces the appointment of Dr. Georg Hochwimmer to the Companys Board of Directors, effective December 29, 2023. Dr. Hochwimmer is Ch...
Date: December 11, 2023 Jurisdictions: Alberta, British Columbia, Ontario
Form 51-102F3 1 Form 51-102F3 Material Change Report 1. Name and Address of Company Nova Mentis Life Science Corp. 700-838 W Hastings Street Vancouver, BC, V6C 0A6 (the Company) 2. Dates of Material Change(s) December 6, 2023 3. News Release(s) A news release ...
1 Nova Mentis Announces Change of Directors and Officers Vancouver, British Columbia December 8, 2023 Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (NOVA or the Company) announces the resignation of Dr. Stephen Glazer as Chief Scientific Officer and a Director of the Company, effective December 6, 2023. I...